Gastrin-releasing peptide receptors in the central nervous system: Role in brain function and as a drug target

Frontiers in Endocrinology

Volumn 3, Issue DEC, 2012, Pages

  Roesler, Rafael ^a,b   Schwartsmann, Gilberto ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b National Institute for Translational Medicine   (Brazil)

Author keywords

Bombesin receptors; Brain disorders; Gastrin releasing peptide; Gastrin releasing peptide receptor; Neuropeptide signaling

Indexed keywords

EID: 84874379103     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00159     Document Type: Review

References (135)

1. Abujamra, A.L., Almeida, V.R., Brunetto, A. L., Schwartsmann, G., and Roesler, R. (2009). A gastrinreleasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor. Cell Biol. Int. 33, 899-903.
2. Battey, J., and Wada, E. (1991). Two distinct receptor subtypes for mammalian bombesin-like peptides. Trends Neurosci. 14, 524-528.
3. Battey, J. F., Way, J. M., Corjay, M. H., Shapira, H., Kusano, K., Harkins, R., et al. (1991). Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 88, 395-399.
4. Bissette, G., Nemeroff, C. B., Decker, M. W., Kizer, J. S., Agid, Y., and Javoy-Agid, F. (1985). Alterations in regionalbrainconcentrationsof neurotensinandbombesininParkinson's disease. Ann. Neurol. 17, 324-328.
5. Brown, M., Rivier, J., and Vale, W. (1977). Bombesin: potent effects on thermoregulation in the rat. Science 196, 998-1000.
6. Brown, M. R., Rivier, J., and Vale, W. W. (1977). Bombesin affects the central nervous system to produce hyperglycemia in rats. Life Sci. 21, 1729-1734.
7. Chaperon, F., Fendt, M., Kelly, P. H., Lingenhoehl, K., Mosbacher, J., Olpe, H. R., et al. (2012). Gastrin-releasing peptide signaling plays a limited and subtle role in amygdala physiology and aversive memory. PLoS ONE 7:e34963. doi: 10.1371/journal.pone.0034963
8. Chan, A. S., and Wong, Y. H. (2005). Gq-mediated activation of c-Jun N-terminal kinase by the gastrin-releasing peptide-preferring bombesin receptor is inhibited upon costimulation of the Gs-coupled dopamine D1 receptor in COS-7 cells. Mol. Pharmacol. 68, 1354-1364.
9. Chatzistamou, I., Schally, A. V., Sun, B., Armatis, P., and Szepeshazi, K. (2000). Inhibition of growth of OV1063 human epithelial ovarian cancers and cjun and cfos oncogene expression by bombesin antagonists. Br. J. Cancer 83, 906-913.
10. Chen, P. W., and Kroog, G. S. (2004). Alterations in receptor expression or agonist concentration change the pathways gastrin-releasing peptide receptor uses to regulate extracellular signal-regulated kinase. Mol. Pharmacol. 66, 1625-1634.
11. Cornelio, D., Roesler, R., and Schwartsmann, G. (2007). Gastrin-releasing peptidereceptorasamoleculartarget in experimental anticancer therapy. Ann. Oncol. 18, 1457-1466.
12. Czepielewski, R. S., Porto, B. N., Rizzo, L. B., Roesler, R., Abujamra, A. L., Pinto, L. G., et al. (2012). Gastrinreleasing peptide receptor (GRPR) mediates chemotaxis in neutrophils. Proc. Natl. Acad. Sci. U.S.A. 109, 547-552.
13. Dantas, A. S., Luft, T., Henriques, J. A., Schwartsmann, G., and Roesler, R. (2006). Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: possible involvement of the GABAergic system. Peptides 27, 2307-2312.
14. de Farias, C. B., Lima, R. C., Lima, L. O., Flores, D. G., Meurer, L., Brunetto, A. L., et al. (2008). Stimulation of proliferation of U138-MG glioblastoma cells by gastrin-releasing peptide in combination with agents that enhance cAMP signaling. Oncology 75, 27-31.
15. de Farias, C. B., Rosemberg, D. B., Heinen, T. E., Koehler-Santos, P., Abujamra, A. L., Kapczinski, F., et al. (2010). BDNF/TrkB content and interaction with gastrinreleasing peptide receptor blockade in colorectal cancer. Oncology 79, 430-439.
16. de Oliveira, M. S., Cechim, G., Braganhol, E., Santos, D. G., Meurer, L., de Castro, C.G. Jr., et al. (2009). Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models. J. Neurooncol. 93, 191-201.
17. Del Rio, M., and De la Fuente, M. (1994). Chemoattractant capacity of bombesin, gastrin-releasing peptide and neuromedin C is mediated through PKC activation in murine peritonealleukocytes.Regul.Pept.49, 185-193.
18. Erspamer, V., Erpamer, G. F., and Inselvini, M. (1970). Some pharmacological actions of alytesin and bombesin. J. Pharm. Pharmacol. 22, 875-876.
19. Fekete, E., Vígh, J., Bagi, E. E., and Lénárd, L. (2002). Gastrin-releasing peptide microinjected into the amygdala inhibits feeding. Brain Res. 955, 55-63.
20. Fleming, M. S., Ramos, D., Han, S. B., Zhao, J., Son, Y.J., andLuo, W.(2012). The majority of dorsal spinal cord gastrin releasing peptide is synthesized locally whereas neuromedin B is highly expressed in painand itchsensingsomatosensoryneurons.Mol. Pain 8, 52.
21. Flood, J. F., and Morley, J. E. (1988). Effects of bombesin and gastrinreleasing peptide on memory processing. Brain Res. 460, 314-322.
22. Flores, D. G., de Farias, C. B., Leites, J., de Oliveira, M. S., Lima, R. C., Tamajusuku, A. S., et al. (2008). Gastrin-releasing peptide receptors regulate proliferation of C6 Glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism. Curr.Neurovasc.Res.5, 99-105.
23. Flores, D. G., Meurer, L., Uberti, A. F., Macedo, B. R., Lenz, G., Brunetto, A. L., et al. (2010). Gastrin-releasing peptide receptor content in human glioma and normal brain. Brain Res. Bull. 82, 95-98.
24. Frank, G. K., Kaye, W. H., Ladenheim, E. E., and McConaha, C. (2001). Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa. Appetite 37, 9-14.
25. Garcia, V. A., Dornelles, A. S., PrestiTorres, J., Alcalde, L. A., Halmenschlager, L. H., Schwartsmann, G., et al. (2010). Neonatal gastrinreleasing peptide receptor blockade reduces maternal odor preference in rats. Behav. Brain Res. 214, 456-459.
26. Gerner, R. H., van Kammen, D. P., and Ninan, P. T. (1985). Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals. Prog. Neuropsychopharmacol. Biol. Psychiatry 9, 73-82.
27. Gibbs, J. (1985). Effect of bombesin on feeding behavior. Life Sci. 37, 147-153.
28. Gibbs, J., Kulkosky, P.J., andSmith, G.P. (1981). Effectsof peripheralandcentral bombesin on feeding behavior of rats. Peptides 2(Suppl. 2), 179-183.
29. Gibson, G. E., Vestling, M., Zhang, H., Szolosi, S., Alkon, D., Lannfelt, L., et al. (1997). Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation. Neurobiol. Aging 18, 573-580.
30. Gonzalez, N., Moody, T. W., Igarashi, H., Ito, T., and Jensen, R. T. (2008). Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr. Opin. Endocrinol. Diabetes Obes. 15, 58-64.
31. Gutzwiller, J. P., Drewe, J., Hildebrand, P., Rossi, L., Lauper, J. Z., and Beglinger, C. (1994). Effect of intravenous human gastrin-releasing peptide on food intake in humans. Gastroenterology 106, 1168-1173.
32. Hampton, L. L., Ladenheim, E. E., Akeson, M., Way, J. M., Weber, H. C., Sutliff, V. E., et al. (1998). Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95, 3188-3192.
33. Hellmich, M. R., Ives, K. L., Udupi, V., Soloff, M. S., Greeley, G.H. Jr., Christensen, B. N., et al. (1999). Multiple protein kinase pathways are involved in gastrin-releasing peptide receptorregulated secretion. J. Biol. Chem. 274, 23901-23909.
34. Hodges, L. M., Weissman, M. M., Haghighi, F., Costa, R., Bravo, O., Evgrafov, O., et al. (2009). Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1inpanicdisorder.Am. J. Med. Genet. BNeuropsychiatr. Genet. 150B, 65-73.
35. Hökfelt, T., Bartfai, T., and Bloom, F. (2003). Neuropeptides: opportunitiesfordrugdiscovery. LancetNeurol. 2, 463-472.
36. Hohla, F., Schally, A. V., Kanashiro, C. A., Buchholz, S., Baker, B., Kannadka, C., et al. (2007). Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt. Proc. Natl. Acad. Sci. U.S.A. 104, 18671-18676.
37. Ishikawa-Brush, Y., Powell. J. F., Bolton. P., Miller. A. P., Francis, F., Willard, H.F., et al. (1997).Autismandmultiple exostoses associated with an X;8 translocation occ′urring within the GRPR gene and 3 to the SDC2 gene. Hum. Mol. Genet. 6, 1241-1250.
38. Ishola, T. A., Kang, J., Qiao, J., Evers, B. M., and Chung, D. H. (2007). Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells. Biochim. Biophys. Acta 1770, 927-932.
39. 2+ mobilization is altered in fibroblasts from patientswithAlzheimerdisease.Proc. Natl. Acad. Sci. U.S.A. 91, 534-538.
40. Jensen, R. T., Battey, J. F., Benya, R. V., and Spindel, E. R. (2008). Bombesin Receptors. IUPHAR Database (IUPHAR-DB). Available at: http://www. iuphar-db.org/DATABASE/Family MenuForward?familyId=9 [accessed on October 1, 2012].
41. Jensen, R. T., Battey, J. F., Spindel, E. R., and Benya, R. V. (2008). International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol. Rev. 60, 1-42.
42. Jensen, R. T., and Gardner, J. D. (1981). Identificationandcharacterizationof receptors for secretagogues on pancreatic acinar cells. Fed. Proc. 40, 2486-2496.
43. Kamichi, S., Wada, E., Aoki, S., Sekiguchi, M., Kimura, I., and Wada, K. (2005). Immunohistochemical localization of gastrin-releasing peptide receptor in the mouse brain. Brain Res. 1032, 162-170.
44. Kauer-Sant'Anna, M., Andreazza, A. C., Valvassori, S. S., Martins, M. R., Barbosa, L. M., Schwartsmann, G., et al. (2007). A gastrin-releasing peptide receptor antagonist blocks D-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats. Peptides 28, 1447-1452.
45. Kiaris, H., Schally, A. V., Sun, B., Armatis, P., and Groot, K. (1999). Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide. Oncogene 18, 7168-7173.
46. Kim, S., Hu, W., Kelly, D. R., Hellmich, M. R., Evers, B. M., and Chung, D. H. (2002). Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann. Surg. 235, 621-629.
47. Kozyrev, N., Lehman, M. N., and Coolen, L. M. (2012). Activation of gastrin-releasing peptide receptors in the lumbosacral spinal cord is required for ejaculation in male rats. J. Sex. Med. 9, 1303-1318.
48. Ladenheim, E.E., Hampton, L.L., Whitney, A. C., White, W. O., Battey, J. F., and Moran, T. H. (2002). Disruptions in feeding and body weight control in gastrin-releasing peptide receptordeficientmice. J.Endocrinol. 174, 273-281.
49. Ladenheim, E. E., Jensen, R. T., Mantey, S. A., McHugh, P. R., and Moran, T. H.(1990).Receptorheterogeneityfor bombesin-likepeptidesintheratcentral nervous system. Brain Res. 537, 233-240.
50. Ladenheim, E. E., Jensen, R. T., Mantey, S. A., McHugh, P. R., and Moran, T. H. (1992). Distinct distributions of bombesin receptor subtypes in the rat central nervous system. Brain Res. 593, 168-178.
51. Ladenheim, E. E., Taylor, J. E., Coy, D. H., Moore, K. A., and Moran, T. H. (1996). Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP. Am. J. Physiol. 271(Pt 2), R180-R184.
52. Lebacq-Verheyden, A. M., Krystal, G., Sartor, O., Way, J., and Battey, J. F. (1988). The rat prepro gastrin releasing peptide gene is transcribed from two initiation sites in the brain. Mol. Endocrinol. 2, 556-563.
53. Liu, X., Carlisle, D. L., Swick, M. C., Gaither-Davis, A., Grandis, J. R., and Siegfried, J. M. (2007). Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib. Exp. Cell Res. 313, 1361-1372.
54. Liu, X.Y., Liu, Z.C., Sun, Y.G., Ross, M., Kim, S., Tsai, F. F., et al. (2011). Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 147, 447-458.
55. Luft, T., Amaral, O. B., Schwartsmann, G., and Roesler, R. (2008). Transient disruption of fear-related memory by post-retrieval inactivation of gastrin-releasing peptide or N-methyl-D-aspartate receptors in the hippocampus. Curr. Neurovasc. Res. 5, 21-27.
56. Luft, T., Flores, D. G., Vianna, M. R., Schwartsmann, G., Roesler, R., and Izquierdo, I. (2006). A role for hippocampal gastrin-releasing peptide receptors in extinction of aversive memory. Neuroreport 17, 935-939.
57. Martel, G., Hevi, C., Wong, A., Zushida, K., Uchida, S., and Shumyatsky, G. P. (2012). Murine GRPR and stathmin control in opposite directions both cued fear extinction and neural activities of the amygdala and prefrontal cortex. PLoS ONE 7:e30942. doi: 10.1371/journal.pone.0030942
58. Martins, M. R., Reinke, A., Valvassori, S. S., Machado, R. A., Quevedo, J., Schwartsmann, G., et al. (2005). Non-associative learning and anxiety in rats treated with a single systemic administration of the gastrinreleasing peptide receptor antagonist RC-3095. Peptides 26, 2525-2529.
59. Marui, T., Hashimoto, O., Nanba, E., Kato, C., Tochigi, M., Umekage, T., et al. (2004). Gastrin-releasing peptide receptor (GRPR) locus in Japanese subjects with autism. Brain Dev. 26, 5-7.
60. Meller, C.A., Henriques, J.A., Schwartsmann, G., and Roesler, R. (2004). The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK801-induced stereotypy in mice. Peptides 25, 585-588.
61. Merali, Z., Hayley, S., Kent, P., McIntosh, J., Bédard, T., and Anisman, H. (2009). Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesinlike peptides at the anterior pituitary. Behav. Brain Res. 198, 105-112.
62. Merali, Z., Kent, P., and Anisman, H. (2002). Role of bombesin-related peptides in the mediation or integration of the stress response. Cell. Mol. Life Sci. 59, 272-287.
63. Merali, Z., Kent, P., Du, L., Hrdina, P., Palkovits, M., Faludi, G., et al. (2006). Corticotropin-releasing hormone, arginine vasopressin, gastrinreleasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol. Psychiatry 59, 594-602.
64. Merali, Z., McIntosh, J., and Anisman, H. (1999). Role of bombesin-related peptidesinthecontroloffoodintake. Neuropeptides 33, 376-386.
65. Merali, Z., Mountney, C., Kent, P., and Anisman, H. (2011). Effects of intracerebral ventricular administration of gastrin-releasing peptide and its receptor antagonist RC-3095 on learned fear responses in the rat. Behav. Brain Res. 216, 519-524.
66. Minamino, N., Kangawa, K., and Matsuo, H. (1983). Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem. Biophys.Res.Commun.114, 541-548.
67. Minamino, N., Kangawa, K., and Matsuo, H. (1984). Neuromedin C: a bombesin-like peptide identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 119, 14-20.
68. Moody, T. W., Getz, R., O'Donohue, T. L., and Rosenstein, J. M. (1988). Localization of receptors for bombesin-like peptides in the rat brain. Ann. N. Y. Acad. Sci. 547, 114-130.
69. Moody, T. W., and Merali, Z. (2004). Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications. Peptides 25, 511-520.
70. Moody, T. W., Mahmoud, S., Staley, J., Naldini, L., Cirillo, D., South, V., et al. (1989). Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide. J. Mol. Neurosci. 1, 235-242.
71. Moody, T. W., O'Donohue, T. L., and Jacobowitz, D. M. (1981). Biochemical localization and characterization of bombesin-like peptides in discrete regionsofratbrain.Peptides2, 75-79.
72. Moody, T. W., and Pert, C. B. (1979). Bombesin-like peptides in rat brain: quantitation and biochemical characterization. Biochem. Biophys. Res. Commun. 90, 7-14.
73. Moody, T. W., Pert, C. B., Rivier, J., and Brown, M. R. (1978). Bombesin: specific binding to rat brain membranes. Proc. Natl. Acad. Sci. U.S.A. 75, 5372-5376.
74. Moody, T. W., Staley, J., Zia, F., Coy, D. H., and Jensen, R. T. (1992). Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small cell lung cancer cell lines. J. Pharmacol. Exp. Ther. 263, 311-317.
75. Mountney, C., Anisman, H., and Merali, Z. (2008). Effects of gastrinreleasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat. Psychopharmacology (Berl.) 200, 51-58.
76. Mountney, C., Anisman, H., and Merali, Z. (2011). In vivo levels of corticotropin-releasing hormone and gastrin-releasing peptide at the basolateral amygdala and medial prefrontal cortex in response to conditioned fear in the rat. Neuropharmacology 60, 410-417.
77. Mountney, C., Sillberg, V., Kent, P., Anisman, H., and Merali, Z. (2006). The role of gastrin-releasing peptide on conditioned fear: differential corticalandamygdaloidresponsesinthe rat. Psychopharmacology (Berl.) 189, 287-296.
78. Niebergall-Roth, E., and Singer, M. V. (2001). Central and peripheral neural control of pancreatic exocrine secretion. J. Physiol. Pharmacol. 52, 523-538.
79. Oh, D. Y., Kim, K., Kwon, H. B., and Seong, J. Y. (2006). Cellular and molecular biology of orphan G protein-coupled receptors. Int. Rev. Cytol. 252, 163-218.
80. Ohki-Hamazaki, H., Iwabuchi, M., and Maekawa, F. (2005). Development and function of bombesin-like peptides and their receptors. Int. J. Dev. Biol. 49, 293-300.
81. Olincy, A., Leonard, S., Young, D. A., Sullivan, B., and Freedman, R. (1999). Decreased bombesin peptide response to cigarette smoking in schizophrenia. Neuropsychopharmacology 20, 52-59.
82. Petronilho, F., Vuolo, F., Galant, L. S., Constantino, L., Tomasi, C. D., Giombelli, V. R., et al. (2012). Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling. Mol. Med. doi: 10.2119/molmed.2012.00083. [Epub ahead of print].
83. Pinski, J., Schally, A. V., Halmos, G., Szepeshazi, K., and Groot, K. (1994). Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res. 54, 5895-5901.
84. Preissler, T., Luft, T., Kapczinski, F., Quevedo, J., Schwartsmann, G., and Roesler, R. (2007). Basic fibroblast growth factor prevents the memory impairment induced by gastrin-releasing peptide receptor antagonism in area CA1 of the rat hippocampus. Neurochem. Res. 32, 1381-1386.
85. Presti-Torres, J., de Lima, M. N., Scalco, F. S., Caldana, F., Garcia, V. A., Guimarães, M. R., et al. (2007). Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: implications for an animal model of neurodevelopmental disorders. Neuropharmacology 52, 724-732.
86. Presti-Torres, J., Garcia, V.A., Dornelles, A., Halmenschlager, L. H., Alcalde, L. A., Vedana, G., et al.(2012).Rescueof social behavior impairment by clozapineandalterationsintheexpression of neuronal receptors in a rat model of neurodevelopmental impairment induced by GRPR blockade. J. Neural Transm. 119, 319-327.
87. Qiao, J., Kang, J., Ishola, T. A., Rychahou, P. G., Evers, B. M., and Chung, D. H. (2008). Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma. Proc. Natl. Acad. Sci. U.S.A. 105, 12891-12896.
88. Rashidy-Pour, A., and Razvani, M. E. (1998).Unilateralreversibleinactivations of the nucleus tractus solitarius and amygdala attenuate the effects of bombesin on memory storage. Brain Res. 814, 127-132.
89. Roesler, R., Brunetto, A. T., Abujamra, A. L., de Farias, C. B., Brunetto, A. L., and Schwartsmann, G. (2010). Current and emerging molecular targets in glioma. Expert Rev. Anticancer Ther. 10, 1735-1751.
90. Roesler, R., Henriques, J. A., and Schwartsmann, G. (2004). Neuropeptides and anxiety disorders: bombesin receptors as novel therapeutic targets. Trends Pharmacol. Sci. 25, 241-242.
91. Roesler, R., Kopschina, M. I., Rosa, R. M., Henriques, J. A., Souza, D. O., and Schwartsmann, G. (2004). RC3095, a bombesin/gastrin-releasing peptide receptor antagonist, impairs aversive but not recognition memory in rats. Eur. J. Pharmacol. 486, 35-41.
92. Roesler, R., Lessa, D., Venturella, R., Vianna, M. R., Luft, T., Henriques, J. A., et al. (2004). Bombesin/gastrinreleasing peptide receptors in the basolateral amygdala regulate memory consolidation. Eur. J. Neurosci. 19, 1041-1045.
93. Roesler, R., Henriques, J. A., and Schwartsmann, G. (2006). Gastrinreleasing peptide receptor as a molecular target for psychiatric and neurological disorders. CNS Neurol. Disord. Drug Targets 5, 197-204.
94. Roesler, R., Luft, T., Oliveira, S. H., Farias, C.B., Almeida, V.R., Quevedo, J., et al. (2006). Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus. Neuropharmacology 51, 350-357.
95. Roesler, R., Kent, P., Schröder, N., Schwartsmann, G., and Merali, Z. (2012). Bombesin receptor regulationof emotionalmemory. Rev. Neurosci. 23, 571-586.
96. Roesler, R., Meller, C. A., Kopschina, M. I., Souza, D. O., Henriques, J. A., and Schwartsmann, G. (2003). Intrahippocampal infusion of the bombesin/gastrin-releasing peptide antagonist RC-3095 impairs inhibitory avoidance retention. Peptides 24, 1069-1074.
97. Roesler, R., Valvassori, S. S., Castro, A. A., Luft, T., Schwartsmann, G., and Quevedo, J. (2009). Phosphoinositide 3-kinase is required for bombesin-induced enhancement of fear memory consolidation in the hippocampus. Peptides 30, 1192-1196.
98. Ruff, M., Schiffmann, E., Terranova, V., and Pert, C. B. (1985). Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. Clin. Immunol. Immunopathol. 37, 387-396.
99. Rushing, P. A., Gibbs, J., and Geary, N. (1996). Brief, meal-contingent infusions of gastrin-releasing peptide1- 27 and neuromedin B-10 inhibit spontaneous feeding in rats. Physiol. Behav. 60, 1501-1504.
100. Rushing, P. A., and Houpt, T. A. (1999). Gastrin-releasing peptide suppresses independentbutnotintraoralintake. Peptides 20, 737-741.
101. Sakamoto, H.(2010).Theneurobiology of psychogenic erectile dysfunction in the spinal cord. J. Androl. 31, 519-526.
102. Sakamoto, H. (2011). Gastrin-releasing peptide system in the spinal cord mediates masculine sexual function. Anat. Sci. Int. 86, 19-29.
103. Sakamoto, H., and Kawata, M. (2009). Gastrin-releasing peptide system in the spinal cord controls male sexualbehaviour. J.Neuroendocrinol. 21, 432-435.
104. Sakamoto, H., Matsuda, K., Zuloaga, D. G., Hongu, H., Wada, E., Wada, K., et al. (2008). Sexually dimorphic gastrin releasing peptide system in the spinal cord controls male reproductive functions. Nat. Neurosci. 11, 634-636.
105. Sakamoto, H., Matsuda, K., Zuloaga, D. G., Nishiura, N., Takanami, K., Jordan, C. L., et al. (2009). Stress affectsagastrin-releasingpeptidesystem in the spinal cord that mediates sexualfunction:implicationsforpsychogenic erectile dysfunction. PLoS ONE 4:e4276. doi: 10.1371/journal.pone.0004276
106. Sakamoto, H., Takanami, K., Zuloaga, D. G., Matsuda, K., Jordan, C. L., Breedlove, S. M., et al. (2009). Androgen regulates the sexually dimorphic gastrin-releasing peptide system in the lumbar spinal cord that mediates male sexual function. Endocrinology 150, 3672-3679.
107. Salio, C., Lossi, L., Ferrini, F., and Merighi, A. (2006). Neuropeptides as synaptic transmitters. Cell Tissue Res. 326, 583-598.
108. Santo-Yamada, Y., Yamada, K., Wada, E., Goto, Y., and Wada, K. (2003). Blockade of bombesin-like peptide receptors impairs inhibitory avoidance learning in mice. Neurosci. Lett. 340, 65-68.
109. Schmidt, A. L., de Farias, C. B., Abujamra, A.L., Kapczinski, F., Schwartsmann, G., Brunetto, A. L., et al. (2009). BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells. J. Mol. Neurosci. 40, 303-310.
110. Schubert, M. L., Hightower, J., Coy, D. H., and Makhlouf, G. M. (1991). Regulation of acid secretion by bombesin/GRP neurons of the gastric fundus. Am. J. Physiol. 260, G156-G160.
111. Schwartsmann, G., DiLeone, L. P., Horowitz, M., Schunemann, D., Cancella, A., Pereira, A. S., et al. (2006). A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest. New Drugs 24, 403-412.
112. Seidita, G., Mirisola, M., D'Anna, R. P., Gallo, A., Jensen, R. T., Mantey, S. A., et al. (2008). Analysis of the gastrinreleasing peptide receptor gene in Italianpatientswithautismspectrum disorders. Am.J.Med.Genet.BNeuropsychiatr. Genet. 147B, 807-813.
113. Sharif, T. R., Luo, W., and Sharif, M. (1997). Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines;roleinmitogenesisandinstimulatingthemitogen-activatedprotein kinasepathway.Mol.Cell.Endocrinol. 130, 119-130.
114. Shumyatsky, G. P., Tsvetkov, E., Malleret, G., Vronskaya, S., Hatton, M., Hampton, L., et al. (2002). Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell 111, 905-918.
115. Spindel, E. R., Chin, W. W., Price, J., Rees, L. H., Besser, G. M., and Habener, J. F. (1984). Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc. Natl. Acad. Sci. U.S.A. 81, 5699-5703.
116. Spindel, E. R., Giladi, E., Brehm, P., Goodman, R. H., and Segerson, T. P. (1990). Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol. Endocrinol. 4, 1956-1963.
117. Stangelberger, A., Schally, A. V., Varga, J. L., Zarandi, M., Cai, R. Z., Baker, B., et al. (2005). Inhibition of human androgen-independent PC3 and DU-145 prostate cancers by antagonists of bombesin and growth hormonereleasinghormoneislinked to PKC, MAPK and c-jun intracellular signalling. Eur. J. Cancer 41, 2735-2344.
118. Stoddard, S. L., Tyce, G. M., Ahlskog, J. E., Zinsmeister, A. R., Nelson, D. K., and Carmichael, S. W. (1991). Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla. Exp. Neurol. 114, 23-27.
119. Sun, Y. G., and Chen, Z. F. (2007). A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448, 700-703.
120. Sun, Y. G., Zhao, Z. Q., Meng, X. L., Yin, J., Liu, X. Y., and Chen, Z. F. (2009). Cellular basis of itch sensation. Science 325, 1531-1534.
121. Szepeshazi, K., Schally, A. V., Halmos, G., Lamharzi, N., Groot, K., and Horvath, J. E. (1997). A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers. Proc. Natl. Acad. Sci. U.S.A. 94, 10913-10918.
122. Thaw, A. K., Smith, J. C., and Gibbs, J. (1998). Mammalian bombesin-like peptides extend the intermeal interval in freely feeding rats. Physiol. Behav. 64, 425-428.
123. Thomas, S. M., Grandis, J. R., Wentzel, A. L., Gooding, W. E., Lui, V. W., and Siegfried, J. M. (2005). Gastrinreleasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells. Neoplasia 7, 426-431.
124. Venturella, R., Lessa, D., Luft, T., Roozendaal, B., Schwartsmann, G., and Roesler, R. (2005). Dexamethasone reverses the memory impairment induced by antagonism of hippocampal gastrin-releasing peptide receptors. Peptides 26, 821-825.
125. von Schrenck, T., Heinz-Erian, P., Moran, T., Mantey, S. A., Gardner, J. D., and Jensen, R. T. (1989). Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am. J. Physiol. 256, G747-G758.
126. von Schrenck, T., Wang, L. H., Coy, D. H., Villanueva, M. L., Mantey, S., and Jensen, R. T. (1990). Potent bombesin receptor antagonists distinguish receptor subtypes. Am. J. Physiol. 259, G468-G473.
127. Wada, E., Way, J., Lebacq-Verheyden, A. M., and Battey, J. F. (1990). Neuromedin B and gastrin-releasing peptidemRNAsaredifferentiallydistributed in the rat nervous system. J. Neurosci. 10, 2917-2930.
128. Wada, E., Way, J., Shapira, H., Kusano, K., Lebacq-Verheyden, A.M., Coy, D., et al. (1991). cDNA cloning, characterization, and brain region-specific expression of a neuromedin Bpreferring bombesin receptor. Neuron 6, 421-430.
129. Wada, E., Wray, S., Key, S., and Battey, J. (1992). Comparison of gene expressionfortwodistinctbombesinreceptor subtypes in postnatal rat central nervous system. Mol. Cell. Neurosci. 3, 446-460.
130. 2+ and phosphoinositides. Biochem. J. 286, 641-648.
131. Williams, C. L., and McGaugh, J. L. (1994). Enhancement of memory processing in an inhibitory avoidance and radial maze task by posttraining infusion of bombesin into the nucleus tractus solitarius. Brain Res. 654, 251-256.
132. Wolf, S. S., and Moody, T. W. (1985). Receptors for GRP/bombesin-like peptides in the rat forebrain. Peptides 6(Suppl. 1), 111-114.
133. Wolf, S. S., Moody, T. W., O'Donohue, T. L., Zarbin, M. A., and Kuhar, M. J. (1983). Autoradiographic visualization of rat brain binding sites for bombesin-like peptides. Eur. J. Pharmacol. 87, 163-164.
134. Wong, S. T., Athos, J., Figueroa, X. A., Pineda, V. V., Schaefer, M. L., Chavkin, C. C., et al. (1999). Calcium-stimulated adenylyl cyclase activity is critical for hippocampusdependent long-term memory and late phase LTP. Neuron 23, 787-798.
135. Zarbin, M. A., Kuhar, M. J., O'Donohue, T. L., Wolf, S. S., and Moody, T. W. (1985). Autoradiographic localization of (125ITyr4)bombesin-binding sites in rat brain. J. Neurosci. 5, 429-437.